Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

110 results
Display

Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study

Park SJ, Kim J, Kim HS, Lee JW, Chang HK, Lee KH, Kim DY, Kim S, Chang SJ, Han SS, Park SY, Shim SH

OBJECTIVE: To evaluate the effectiveness and safety of the combination of pegylated liposomal doxorubicin with carboplatin (CD) compared with those of carboplatin and paclitaxel (CP) for platinum-sensitive recurrent ovarian, fallopian,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series

Hur JY, Park SH, Lee SJ

PURPOSE: Soft tissue sarcomas (STS) are a rare and heterogeneous tumor group with limited treatment options. This study aimed to evaluate the anti-tumor efficacy of olaratumab and doxorubicin in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway

Liu CL, Chen MJ, Lin JC, Lin CH, Huang WC, Cheng SP, Chen SN, Chang YC

PURPOSE: Cancer cells develop acquired resistance induced by chemotherapeutic drugs. In this study, we investigated the effects of brief treatment with cytotoxic drugs on the phenotype of breast cancer cells. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Loss of endogenous estrogen increases cardiac toxicity by doxorubicin

Lee YH, Lee SR, Kwon SW, Lee SY, Park BK, Hong EJ

Breast cancer is of enormous concern worldwide and linked with age, sex, hormonal factors, and family history. The treatment of early breast cancer includes treating the disease locally with surgery,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience

Lee YJ, Kim YM, Lee SW, Park JY, Kim DY, Suh DS, Kim JH, Kim YT, Nam JH

OBJECTIVE: This study aimed to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) with or without carboplatin in Korean patients with recurrent ovarian cancer (ROC), fallopian tube, or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells

Kumar A, Bhatkar D, Jahagirdar D, Sharma NK

Among the genotoxic drug regimens, doxorubicin (DOX) is known for its high-dose side effects in several carcinomas, including cervical cancer. This study reports on testing the combined use of a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Shin J, Lee JO, Choe JY, Bang SM, Lee JS

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin’s lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer

Sohn G, Ahn SH, Kim HJ, Son BH, Lee JW, Ko BS, Lee Y, Lee SB, Baek S

PURPOSE: The purpose of this study was to compare treatment outcomes between combined gonadotropin-releasing hormone agonist and tamoxifen (GnRHa+T) and sequential adriamycin and cyclophosphamide chemotherapy and tamoxifen (AC->T) in premenopausal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres

Ryoo IG, Kim G, Choi BH, Lee SH, Kwak MK

Cancer stem cells (CSCs) are a subset of tumor cells, which are characterized by resistance against chemotherapy and environmental stress, and are known to cause tumor relapse after therapy. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma

Khedr GA, Elzawawy S, Gowil AG, Elyamany A, Eshafei M

PURPOSE: We evaluated oral metronomic capecitabine (MC) compared to intravenous doxorubicin in patients with advanced or metastatic hepatocellular carcinoma (HCC). METHODS: From January 2013 to December 2015, patients with Child-Pugh class...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Malignant Glomus Tumor on Shoulder with Pulmonary Metastasis Treated with Doxorubicin and Ifosfamide in a 10-year Old Girl

Jin WS, Jeon IS

Malignant glomus tumor is an exceedingly rare neoplasm occurring in the soft tissues. Controversy exists over whether malignant glomus tumor is a true malignancy due to the rarity of metastasis,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

Ha H, Keam B, Kim TM, Jeon YK, Lee SH, Kim DW, Kim CW, Heo DS

PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Alginate Layer for Improving Doxorubicin Release and Radiolabeling Stability of Chitosan Hydrogels

Kwon JI, Lee CM, Jeong HS, Oh PS, Hwang H, Lim ST, Sohn MH, Jeong HJ

PURPOSE: Chitosan hydrogels (CSH) formed through ionic interaction with an anionic molecule are suitable as a drug carrier and a tissue engineering scaffold. However, the initial burst release of drugs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer

Yoo C, Kim SB, Ahn JH, Kim JE, Jung KH, Gong GY, Son BH, Ahn SH, Ahn SD, Kim HH, Shin HJ, Kim WK

PURPOSE: Given the promising activity of capecitabine and vinorelbine in metastatic breast cancer, this randomized phase II trial evaluated the efficacy and safety of this combination as neoadjuvant chemotherapy in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth

Lee EJ, Ahn KH, Hong SC, Lee EH, Park Y, Kim BS

Lymphoma, especially non-Hodgkin's lymphoma is extremely rare in pregnancy. A 24-year-old pregnant woman was diagnosed with diffuse large B-cell lymphoma (DLBCL), a subgroup of non-Hodgkin's lymphoma, at 24 weeks' gestation,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats

Uhm JS, Chung WB, Yoon JS, Oh YS, Youn HJ

INTRODUCTION: It has been reported that the chemotherapeutic agent, adriamycin, not only has an effect on the myocardium but also on the arteries. The aim of this study is to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone

Niscola P, Palombi M, Fratoni S, Perrotti A, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histological Experimental Study on the Effect of Stem Cell Therapy on Adriamycin Induced Chemobrain

Zickri1 MB, Abd El Aziz DH, Metwally H

  • KMID: 2054550
  • Int J Stem Cells.
  • 2013 Nov;6(2):104-112.
BACKGROUND AND OBJECTIVES: Negative consequences of chemotherapy on brain function were suggested and were addressed in animal models as the clinical phenomenon of chemobrain .It was postulated that adriamycin (ADR)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy

Lim SC

  • KMID: 2048308
  • Biomol Ther.
  • 2013 Sep;21(5):371-380.
Doxorubicin is still main drug in chemotherapy with limitation of use due to adverse drug reaction. Increased oxidative stress and alteration of nitric oxide control have been involved in cardiotoxicity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Increases in Doxorubicin Sensitivity and Radioiodide Uptake by Transfecting shMDR and Sodium/Iodide Symporter Gene in Cancer Cells Expressing Multidrug Resistance

Ahn SJ, Lee YJ, Lee YL, Choi CI, Lee SW, Yoo J, Ahn BC, Lee IK, Lee J

  • KMID: 1518943
  • Nucl Med Mol Imaging.
  • 2007 Jun;41(3):209-217.
PURPOSE: Multidrug resistance (MDR) of the cancer cells related to mdr1 gene expression can be effectively treated by selective short hairpin RNA for mdr1 gene (shMDR). Sodium/iodide symporter (NIS) gene...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr